We have investigated how medical postponement, the time to surgery and the correction of medical abnormalities, according to McLaughlin criteria, before operation affected perioperative mortality after fracture of the hip. From February to December 2007, in addition to core data, the Scottish Hip Fracture Audit collected information relating to surgical delay. Data were available for 4284 patients which allowed 30-day survival analysis to be performed. Multivariable logistic regression models were used to control for differences in case-mix.
We have investigated how medical postponement, the time to surgery and the correction of medical abnormalities, according to McLaughlin criteria, before operation affected perioperative mortality after fracture of the hip. From February to December 2007, in addition to core data, the Scottish Hip Fracture Audit collected information relating to surgical delay. Data were available for 4284 patients which allowed 30-day survival analysis to be performed. Multivariable logistic regression models were used to control for differences in case-mix.
Patients with major clinical abnormalities were more likely to have a postponement and had a lower unadjusted 30-day survival. The time to operation and postponement were not associated with higher mortality after adjustment for case-mix. Correction of major clinical abnormalities before surgery improved the adjusted survival, but this improvement was not significant (p = 0.10). Postponement without correction of a medical abnormality before surgery was associated with a significantly lower (p = 0.006) 30-day adjusted survival. The possible benefits of postponement need to be weighed against prolonged discomfort for the patient and the possibility of the development of other complications.
Fracture of the hip is the most common serious injury in the elderly with an estimated 70 000 new cases in the United Kingdom per annum. 1 Chronic and acute medical problems are common in this group and are associated with a high peri-operative mortality of approximately 14% at 120 days after surgery. 2 Mortality is the most important and frequently reported measure of surgical outcome. A number of patient and management variables have been studied to identify the principal causes of death after surgery for hip fracture. 2 The association between the delay to surgery and peri-operative mortality remains a contentious issue. Reports to date have been contradictory and controversy continues regarding the best management of this common injury. There are a number of reasons for surgical delay including the lack of available resources and the geographical location of the patient. One of the most common is the time taken to improve the medical condition of the patient before operation. 23 In this study we have investigated the relationship between delay in surgery and peri-operative mortality after fracture of the hip.
Patients and Methods
The Scottish Hip Fracture Audit (SHFA) is a national, prospective study which collects data relating to patients over the age of 50 years who are admitted to Scottish hospitals with a fracture of the hip. A standard core dataset is used to collect case-mix, process (e.g. time in emergency department) and outcome data during the acute stay and at 120 days after admission. Data are collected by dedicated audit coordinators. The collection of complete and accurate data is achieved by means of standardised procedures for data collection, dual data entry and a comprehensive electronic validation process.
From February to December 2007, in addition to core data, the SHFA collected information on the fitness of such patients for theatre, the reasons for postponement of surgery and subsequent plans of action. In 56% of the patients studied these data were available from customised assessment sheets completed by medical staff, predominantly anaesthetists, each time they assessed the patient for surgery. If these were not available, audit co-ordinators collected the data and information on all routine tests and observations from the medical notes. Some hospitals did not participate during the full period of the audit, and a small number of patients were excluded because they had been treated conservatively, had refused surgery, or had died before assessment. Despite these periods of non-participation and other exclusions, data were available for 5447 patients, representing 92% of those admitted to hospital following a fracture of the hip in Scotland during this period of 11 months.
Although we routinely review patient outcomes at 120 days after admission, we chose survival at 30 days after operation as our primary outcome measure, since we thought that this would include a high proportion of deaths which were at least partly related to the fracture itself, while limiting the number of unrelated deaths occurring naturally in this elderly population in the second, third and fourth months after surgery. All audited patients were followed until discharge from acute orthopaedic care, but many were discharged from hospital within 30 days. Therefore, the figures on 30-day survival were mainly derived from review data collected at 120 days after admission. One hospital did not collect review data at 120 days, and another stopped collection part way through the period of audit resulting in the loss of outcome data for 921 (16.9%) patients. Additionally, 115 (2.1%) patients or their carers did not respond to the review audit and their 30-day outcome could not be derived from hospital records. We also excluded the 127 (2.3%) patients who had been surgically assessed, but were never deemed to be fit enough for surgery. We used data from the remaining 4284 surgical patients to carry out the 30-day survival analyses.
The clinical assessment data set recorded whether or not a range of medical problems and/or co-morbidities had been identified on routine examination (e.g. heart rhythm, blood results, ECG or chest radiograph) or on clinical examination (e.g. vital signs). This was used to identify 11 classes of pre-operative clinical abnormality, each with major and minor levels, according to the criteria described by McLaughlin et al 24 (Table I) . These major and minor abnormalities are associated with higher rates of postponement of patients after their first theatre assessment. 24 During examination of the data for those patients who did not have major or minor abnormalitities, we identified a third subgroup of patients who had higher than average rates of postponement. Such cases were associated with other 'concerns'. These included observations close to but lower than the McLaughlin limits, or other problems identified on audited examinations which did not constitute McLaughlin abnormalities in their own right (e.g. atrial fibrillation/flutter, cardiac ischaemia or abnormalities on auscultation of the chest).
Although these major or minor clinical abnormalities and concerns were primarily indicative of potential reasons for postponing surgery, we also used the associated 30-day survival rates as indices of the general health of the patients. Each was assigned to one of seven predicted 30-day survival categories (50.0% to 75.0%, 75.0% to 80.0%, 80.0% to 85.5%, 85.0% to 87.5%, 87.5% to 90.0%, 90.0% +, and no abnormalities or concerns) dependent on the lowest survival rate associated with any abnormalities or concerns identified in that patient.
Two measures of surgical delay were used to assess whether it was associated with changes in outcome. Firstly, did the patient have postponement for medical reasons after the first theatre assessment or not? This measure reflected the variation in the opinion of the anaesthetist on whether postponement was likely to be more deleterious than progressing to surgery. Secondly, we examined the length of time between admission and surgery. This was because some postponements after the first theatre assessment may have been very short, hours rather than days, or, conversely, some patients may not have had their operation after their first theatre assessment, but were still delayed for several days by lack of theatre availability, delayed diagnosis or other reasons. For patients with major abnormalities, we examined whether there was any difference in the survival rate for those who had postponement depending on whether their major abnormality was resolved to a degree, or whether they ultimately proceeded to theatre without the abnormality being completely resolved. Other variables in case-mix (e.g. age, gender, American Society of Anesthesiologists (ASA) grade, 25 pre-fracture residence, pre-fracture dependence and mobility) known to be associated with survival after hip fracture were derived from the core SHFA data-set. 2 These factors were used to build base logistic regression models before testing whether the inclusion of the surgical delay variables provided further improvements to the model.
Results
As expected, patients with no identified clinical concerns or abnormalities after their first theatre assessment had the highest predicted 30-day survival and were less likely to have postponement of their operation (Fig. 1 Survival in relation to postponement and time to theatre (unadjusted). Patients who had their operation postponed for medical reasons after their first theatre assessment were less likely to survive to 30 days compared with those who were not postponed (87% (825/947) versus 92.8% (3098/ 3337)). Survival also decreased as the time to operation increased; 92% (2816/3049) of the patients operated on during the same or next day after admission survived to 30 days compared with 89% (284/319) of the patients operated on the fourth day after admission or later. However, this increase in mortality was likely to reflect a combination of delay for medical reasons and surgery in patients who were more seriously ill. In keeping with this, 41% (388/947) of patients who had postponement after their first theatre assessment had major abnormalities compared with only 9% (300/3337) of those who did not have postponement. Only 11% (335/3049) of patients operated on the same or the next day after admission had major clinical abnormalities compared with 26% (238/916) of those operated on the second or third day after admission and 45% (144/319) of those operated on the fourth day after admission or later. Such differences in co-morbidities can obviously act as confounding variables when assessing the relationship between postponement and peri-operative mortality. As such multivariate logistic regression models were used to control for such variables.
Table III presents the improvement in logistic regression models for predicting survival at 30 days after operation if delay is entered into basic models already including age, gender, ASA grade, pre-fracture residence and survival category (significance of basic model: p < 0.001). None of the odds ratios differ significantly from 1.0, indicating that no delay measure enhanced the survival model.
Survival in relation to medical postponement and time to theatre (adjusted). Of the 3337 patients considered to be fit for theatre on the first assessment, 2855 (85.6%) underwent surgery on the same or next day after admission, and 3219 (96.5%) by two days after admission. After controlling for differences in case-mix variables and survival category, we found that neither postponement after the first theatre assessment nor the length of time to theatre significantly improved the survival logistic regression model (Table III) . Nor did these variables improve the base models when analysed separately within any of the seven individual survival categories described previously. In summary, patients who had postponement had lower 30-day survival, but not after proper control for case-mix variables and other medical conditions. Survival in relation to whether or not major abnormalities were resolved. Many patients have postponement after their first theatre assessment to treat or to improve medical conditions which may potentially increase the risk during operation. Does such postponement improve the survival of the patient? For those with major clinical abnormalities who had postponement after the first theatre assessment, data were available (Table IV) to indicate whether or not these major clinical abnormalities were resolved to at least a minor abnormality or not before the patient underwent surgery. The survival of these patients was compared with the series of patients with major clinical abnormalities at the first theatre assessment who did not have postponement. Unadjusted 30-day survival was highest (92.0%) for the patients with major clinical abnormalities which were corrected before they underwent surgery. The patients taken to theatre without postponement and without resolution of major clinical abnormalities had a reduced 30-day survival (87.1%). However, the group which had the poorest outcome included those patients who had postponement, yet their major clinical abnormality was not corrected before surgery, 30-day survival (73.3%). However, the survival figures presented in Table IV were not adjusted for differences in patient case-mix and therefore a logistic regression model was used which again included both case-mix and category of survival. This model was significantly improved by the postponed, resolved variable. Patients who had postponement, but had their clinical abnormality resolved before theatre, had a slightly (but not significantly, p = 0.10) higher 30-day survival than those who did not have postponement. Individuals who had postponement, but did not have their major clinical abnormality resolved before surgery had a significantly lower adjusted 30-day survival. Table V gives the improvement in the survival of patients with major abnormalities at 30 days after operation when we divided the patients into those who did not have postponement at the first assessment, those who initially had postponement, but then had their abnormalities resolved before theatre and those who initially had postponement, but then proceeded to theatre at a later date without complete resolution. Improvement was measured relative to the basic model containing age, ASA grade and survival category (significance of basic model: p < 0.001). The odds ratio, which differed significantly from 1.0, indicated that survival differed from that in patients with major abnormalities who initially did not have postponement.
Discussion
Many patients admitted to hospital after sustaining a fracture of the hip have acute or chronic medical conditions which may affect the outcome of surgery. McLaughlin et al 24 carried out a prospective study of 571 adults with these fractures using multiple logistic regression models to identify risk factors, including 11 categories of physical and laboratory findings, classified as mild and severe abnormalities, associated with complications in hospital. The presence of more than one major clinical abnormality before surgery (odds ratio 9.7, 95% confidence interval (CI) 2.8 to 33.0) or the presence of major abnormalities on admission which were not corrected before surgery (odds ratio 2.8, 95% CI 1.2 to 6.4) was independently associated with the development of post-operative complications. Minor abnormalities, while warranting correction, did not increase risk (odds ratio 0.70, 95% CI 0.28 to 1.73). The authors recommended that major clinical abnormalities should be corrected before surgery, but that patients with minor abnormalities should proceed to surgery with attention to these medical problems peri-operatively. Because of the small number of peri-operative deaths in their series, the authors could not show how clinical abnormalities affected mortality. In our study we have used the criteria of McLaughlin et al 24 to define clinical abnormalities after the first assessment by an anaesthetist and how postponement on this basis may affect peri-operative mortality. As expected, patients with no identified clinical concerns or abnormalities had the highest 30-day survival and were less likely to have postponement. Similarly, those with major clinical abnormalities were most likely to have postponement after the first anaesthetic assessment and had the lowest unadjusted 30-day survival. Such findings reflect the outcome after surgery in the more severely ill patients. In keeping with this, 41% of patients who had postponement after the first theatre assessment had major clinical abnormalities compared with only 9% of those who did not have postponement. Such differences in medical co-morbidity can act as confounding variables when analysing data on mortality. In a previous study of a different series of patients, we reported the important association with mortality of patient case-mix variables including gender, age, ASA grade, type of fracture, pre-fracture mobility and residence. 2 After controlling for differences in case-mix, postponement after the first theatre assessment did not significantly affect the 30-day survival. Nor did these variables improve the base models when analysed separately within any of the seven individual survival categories described previously. In summary, patients who had postponement had a lower 30-day survival, but not after proper control for case-mix variables and medical co-morbidity.
Patients who have major clinical abnormalities identified after the first anaesthetic assessment are often delayed in order to improve their medical condition before surgery. Does this have a positive effect on peri-operative mortality? In order to answer this we performed an analysis of the outcome in the patients with major clinical abnormalities according to whether the medical condition was improved before undergoing surgery. The unadjusted 30-day survival was highest in those patients with major clinical abnormalities who had postponement and in whom their medical condition improved before undergoing surgery (92.0%). Those individuals who underwent surgery without postponement or medical improvement had a relatively reduced 30-day survival (87.1%). However, those who had postponement but were not improved medically before surgery had the poorest outcome (73.3%). Again, these marked differences in survival are likely to reflect underlying comorbidities which themselves affect peri-operative mortality. We therefore used multivariate regression models which included case-mix and survival category. Patients who had postponement, but had their abnormalities resolved before surgery had slightly, but not statistically significantly (p = 0.10) higher survival rates than those who did not have postponement. Those who had a postponement, but then did not have resolution of their condition had significantly lower survival rates (p = 0.006). However, this relationship may still reflect the severity of the patient's medical problems beyond those recorded in our study rather than whether or not postponement or further postponement was appropriate: 29% of patients who had postponement, but did not have resolution before theatre had more than one major abnormality at the first theatre assessment, compared with 11% of those who had postponement and then had resolution, and 8% of those who did not have postponement (chi-squared test: 44, p < 0.001).
The effect of surgical delay and peri-operative mortality after hip fracture continues to be a contentious issue. Within many orthopaedic units the demand for urgent surgery often exceeds the available resources which may result in delay for logistical reasons. In addition to postponement on medical grounds, we have also analysed how the time interval between admission and surgery affects perioperative mortality. There was a progressive reduction in the 30-day survival as the time from admission to surgery increased, from 92.8% in those who underwent surgery on the same or next day after admission to approximately 87.0% in those who had surgery later than the fifth day after admission. This relationship is complicated by the fact that patients with medical co-morbidities are more likely to be subject to surgical delay which may confound the data on mortality. In keeping with this, 11% of patients operated on during the same or next day after admission had major clinical abnormalities compared with 26% of those operated on the second or third day after admission and 45% of those operated on the fourth day after admission or later. After controlling for differences in case-mix and survival category, the length of time to surgery did not significantly affect the peri-operative mortality.
Although there is extensive literature on the association between time to theatre and peri-operative mortality after surgery for hip fracture, our study is unique in that we have been able to document prospectively and comprehensively the reasons for delay in the time to theatre according to established clinical criteria and the effects of improving these clinical abnormalities before surgery. We have also used comprehensive multivariable logistic regression models to control for differences in case-mix. These models were expanded to include medical postponement, time to surgery, survival category (based on the most significant clinical abnormality) and resolution of clinical abnormalities before surgery as additional variables.
The primary aim of the SHFA is to improve the care of patients admitted to hospital after sustaining a hip fracture. The findings of our study may seem initially to suggest that the time to surgery after hip fracture does not significantly affect peri-operative mortality. However, this supposition must be taken in context. In our study 96% of patients assessed as being fit for surgery had gone to theatre by the second day after admission. Therefore most patients who had postponement had so on medical grounds. This reduced delay to theatre for patients with hip fracture in Scotland may reflect the effectiveness of a national government target in combination with the monthly audit and feedback cycle provided by the SHFA. Over the last decade the mortality after hip fracture in Scotland has remained relatively static despite increasing frailty and medical comorbidity among such patients.
The Scottish Government set the standard that 98% of individuals admitted with a hip fracture (if medically fit) should undergo surgery within 24 hours of 'safe operating time' which is defined as 8 am to 8 pm seven days a week. This target has the associated benefit that the patient is more likely to be treated by a senior surgical team and reduces repeated fast/feed cycles. 26 Although we have found no evidence to support the common arbitrary target of surgery within 24 hours of admission, from the patients' point of view it is important that we undertake surgery for hip fractures as soon as it is medically safe to do so. Unnecessary delay in the time to theatre may result in serious complications such as pressure sores or chest infection. 12 In our study 43% (1852/4284) of patients had clinical abnormalities after their first assessment by an anaesthetist and we believe that it is important that these frail patients are treated on dedicated, planned trauma lists after appropriate pre-operative assessment and treatment for medical problems when necessary.
